NHS Addiction Treatment Waiting Times: Why UK Families Are Looking at Private Options Abroad

NHS data shows initial addiction assessments happen fast, but the real bottleneck is residential rehab, where placements have fallen by roughly 50% over the past decade and only around 1% of people in community treatment ever secure a bed. This article walks through what the official statistics actually show, why the system changed, and what UK families can do right now — including private treatment abroad — while a loved one waits.

There is a particular kind of silence that falls after someone finally says the words “I need help.” For a person in the grip of dependency, that admission often takes years to arrive at — and once it does, the fear is that the moment will pass before anyone answers the phone. For the family member sitting on hold with a local drug and alcohol service, phone pressed to their ear, the silence is different but no less frightening: what happens next? How long will this actually take? And what do we do in the meantime, while someone we love is still drinking, still using, still at risk?

This article is not a story about NHS failure. What it describes is a system that has been reshaped, and in many ways stretched, by more than a decade of local-authority commissioning changes and sustained funding pressure. The clinicians and support workers inside community drug and alcohol services are, by every account, doing skilled and compassionate work with a shrinking toolkit. The strain families feel is real, but it sits upstream of any individual service or any individual professional.

Our purpose here is simple: to help families understand what the official data actually shows about NHS addiction treatment waiting times, what it doesn’t show, and what genuine options exist while a loved one waits — including private treatment abroad, which for a growing number of UK families has become a parallel path rather than a last resort.

How Long Are People Really Waiting for NHS Addiction Treatment?

The honest answer starts with a fact that surprises most families: the first step of NHS addiction treatment is usually fast. According to the Office for Health Improvement and Disparities (OHID), in its report “Substance misuse treatment for adults: statistics 2024 to 2025”, between 98% and 99% of people across all substance groups waited three weeks or less for a first intervention in 2024/25. The average wait for that first contact was just 1.3 days overall — 0.7 days for opiate clients and 1.8 days for alcohol-only clients.

Read quickly, that looks like a system working well. And in one specific sense, it is: getting an initial assessment or a brief intervention with a community drug and alcohol service, in most parts of England, does not typically involve a long wait.

But this is where families need to read the data carefully, because “first intervention” is a narrower term than it sounds. It refers to the point at which someone is seen and assessed — a triage conversation, a brief intervention, the start of a care plan within a community setting. It is not the same as securing a place in residential rehabilitation or a medically supervised detox bed. Those are two entirely different stages of treatment, measured in entirely different ways, and conflating them is the single most common misunderstanding families have when they first approach NHS services.

The real bottleneck sits further along the pathway. Residential rehabilitation placements — the kind of structured, live-in treatment that many people with more severe or long-standing dependency actually need — have fallen by roughly 50% over the past decade. According to a Freedom of Information investigation by Phoenix Futures, reported by WRD News, only around 1% of people currently in community treatment ever access residential rehab at all.

So the wait most families feel isn’t really a wait for a phone call to be answered, or an assessment to be booked. It’s a wait for a bed — and that is a very different, and much less predictable, kind of wait.

Why Has Residential Rehab Capacity Shrunk?

To understand why residential places have become so scarce, it helps to go back to 2013, when responsibility for commissioning addiction treatment in England shifted from ring-fenced national funding to local authority public health budgets. Before that change, addiction services were funded through a protected national pot specifically earmarked for substance misuse treatment. After it, that money became part of each council’s wider Public Health Grant — competing, year on year, against every other local public health priority.

The financial consequence of that shift has been well documented. The Royal College of Psychiatrists, in written evidence to Parliament (ATS0003), and in a 13 May 2025 statement on people with substance use and mental health disorders being excluded from care, found that investment in adult substance use services in England has fallen by more than £200 million in real terms, adjusted for inflation, since local authorities took over commissioning in 2013/14.

The workforce has felt this too. Among the trusts and health boards that responded to the Royal College of Psychiatrists, 24% of consultant addiction psychiatrist posts were vacant or being filled by locum staff — a sign of a specialism under sustained strain, not one short of demand.

Phoenix Futures’ FOI research adds further detail to the picture at local level. Around 30% of local authorities report having no defined residential rehab budget at all, meaning that in large parts of the country, funding a residential placement is not a matter of policy but of discretion, negotiated case by case. Researchers involved in that work estimate that approximately £40 million in additional annual funding would be needed just to restore service levels in the highest-deprivation areas back to where they stood in 2014.

None of this is a criticism of the professionals working within community drug and alcohol teams. It is a documented structural and funding issue, built up gradually over more than ten years of commissioning decisions largely made outside the NHS itself — and it is the context every family deserves to understand before they judge how long they’ve been waiting.

What Did the Government’s Own Review of Drug Treatment Find?

Perhaps the clearest official acknowledgement of this strain came from within government itself. Dame Carol Black’s Independent Review of Drugs, Part 2 — commissioned jointly by the Home Office and the Department of Health and Social Care, and published on 8 July 2021 — was blunt in its conclusion: “Funding cuts have left treatment and recovery services on their knees.”

To its credit, the government’s response to that finding was substantial, not merely rhetorical. The subsequent 10-year drug strategy, “From Harm to Hope,” pledged an additional £532 million for treatment and recovery services across the three years from 2022/23 to 2024/25 — one of the largest funding commitments to addiction treatment in England in a generation.

The balanced picture, though, is that even with that investment landing, Phoenix Futures’ 2026 FOI data still shows residential placement numbers down by roughly 50% compared with a decade ago. The additional funding has closed part of the gap opened up since 2013 — it has not closed all of it. This is best understood as encouraging but incomplete progress: a system that has been given real resources to work with, but that is still rebuilding capacity it lost over more than ten years, and hasn’t yet finished the job.

What Happens to a Family While They Wait for a Referral to Progress?

Behind every statistic in this article is a family living through something the numbers can’t fully capture. While a referral moves — or stalls — through the system, families often find themselves absorbing a great deal of uncertainty and repeated administrative work: further risk assessments, re-referrals passed between a GP, a community drug and alcohol team, and, if things progress that far, a residential provider being sought for a funded placement.

There’s rarely a clear date to hold onto. Families are often told that a bed may become available, subject to funding approval and local capacity — but not when, and sometimes not whether at all, particularly outside the areas classified as highest-harm, where resources are naturally concentrated. In the meantime, the person at the centre of it all does not pause. Their condition may fluctuate — better weeks and worse ones, moments of hope followed by relapse or crisis — while the family watches, manages, and waits.

It’s usually at this point, in the space between an assessment that happened quickly and a placement that hasn’t materialised, that families begin researching alternatives for the first time. Not because they’ve lost faith in the principle of NHS care, but because someone they love is in crisis right now, and a system-level fix — however real the investment behind it — doesn’t arrive on the timeline a single family needs. That is the emotional pivot most families experience: they don’t leave the NHS pathway because it’s broken. They look outside it because waiting is not a neutral act when someone’s safety is at stake.

Is Private Rehab Abroad a Realistic Option for a UK Family?

For many families, the idea of private rehab abroad raises immediate and reasonable questions: Can we afford it? Is it too far away to manage as a family? Can we trust the licensing and clinical standards of a facility we’ve never seen, in a country whose healthcare system we don’t know?

These are fair concerns, and they deserve straightforward answers rather than reassurance for its own sake. On cost and access, one structural fact is worth understanding clearly: international private facilities operate entirely outside the NHS and local-authority commissioning system. Their admission timelines are governed by clinical readiness and bed availability at the facility itself — not by a council’s budget cycle or a commissioning calendar tied to the next financial year. That doesn’t make private treatment automatically faster for every individual case, but it does remove an entire layer of the bureaucratic uncertainty that shapes NHS residential wait times.

On cost, it’s also worth knowing that many UK private medical insurance policies — including those from Bupa, AXA, Allianz, and Cigna Global — will reimburse a portion of treatment costs at a licensed overseas facility, even though the NHS itself does not fund treatment abroad. The specifics vary significantly by policy and provider, so we’d point families toward our dedicated article, “Does Insurance Cover Rehab in Thailand“, for the full breakdown of how that process typically works.

On trust and licensing, the right question isn’t whether treatment abroad can be safe — it’s how to verify that a specific facility is. Our article “Is Rehab in Thailand Safe” walks through exactly what to check: Ministry of Public Health licensing, on-site medical oversight, and the credentials of the clinical staff actually delivering care. Any facility worth considering should be able to answer those questions plainly and without hesitation.

How Holina Rehab Offers a Faster Path to Treatment

Holina Rehab was built around a structural difference from the NHS pathway, not a promise about speed in the abstract. Because Holina is privately funded and internationally staffed, there is no waiting list model in the way families experience with council-commissioned services. Admission is governed by clinical assessment and bed availability at our Thailand facility — not by local-authority budget cycles or commissioning timetables.

For some families, privacy matters as much as pace. Our admission process is discreet by design, which is particularly relevant for professionals, public-facing individuals, or any family that wants speed without the process becoming visible to their wider community.

Clinically, our model is built around a small number of core commitments, applied consistently through our Dual Treatment programme: NARM (NeuroAffective Relational Model) and Somatic Therapy for trauma-linked addiction, hyperbaric oxygen therapy (HBOT), medication-assisted treatment where clinically indicated, and mindfulness and Buddhist-influenced practices integrated into daily programming alongside structured family therapy. We use the term behavioural health rather than mental health, and dual treatment rather than dual diagnosis, reflecting how our clinical team understands and describes co-occurring addiction and psychological difficulties in clinical documentation and in conversations with families.

One question we hear from almost every UK family exploring this option is what happens after treatment ends — a natural concern when comparing any private programme to the continuity, however imperfect, of an NHS pathway. Our answer is Thrucare, a two-year structured aftercare programme built specifically to support the period after discharge, when the risk of relapse is often highest and family support matters most.

On cost, we won’t overstate what insurance can do: some UK private insurance policies do partially reimburse treatment at Holina, and we’d encourage any family to read our dedicated insurance article rather than rely on a general estimate here, since the details differ by insurer and policy.

What we can say plainly is this: for a family who has just been told there’s a wait, Holina offers a clinically supervised, licensed alternative that can begin the admission process immediately. That is not a guarantee of any specific timeframe — every case depends on individual clinical circumstances — but it is a genuine, parallel path that doesn’t require choosing between hope and patience.

What Families Can Do Now

If you’re navigating this right now, a few practical steps can help, regardless of which path — or both — you end up taking.

Ask your current NHS or community service directly for their estimated timeline to a funded residential placement, not just the wait for a first assessment. These are two different figures, and it’s reasonable to ask for both explicitly.

Check your existing private medical insurance policy documents for clauses covering “inpatient rehabilitation” or “substance use disorder treatment,” and note any pre-authorisation requirements before you need them urgently.

Request a same-week clinical consultation from a private provider, such as Holina, to speak with our admissions team and understand real admission timing while your NHS referral is still in progress. These paths are not mutually exclusive — many families run both in parallel.

Document everything along the way: GP letters, assessment notes, care plan details. This paperwork supports both NHS referral continuity and any private insurance claim you may later need to make.

Finally, involve the whole family early. Holina’s family therapy component, like most well-designed family therapy, works best when relatives are engaged and informed before admission begins, not brought in afterwards.

Frequently asked questions

How long is the NHS waiting list for drug and alcohol rehab in the UK?

For a first assessment or brief intervention, waits are generally short: OHID reports 98-99% of people across all substance groups waited three weeks or less in 2024/25, with an average wait of 1.3 days. However, residential rehab wait times aren’t published centrally in the same way. The best available proxy for how long the residential stage actually takes is Phoenix Futures’ finding that only around 1% of people in community treatment currently access residential rehab at all.

Why did NHS addiction treatment funding change in 2013?

In 2013, commissioning responsibility for addiction services moved from ring-fenced national NHS funding to local authorities, who now fund treatment through their Public Health Grant. This means addiction services compete against other local public health priorities for funding, rather than drawing on a protected national budget.

Is it true that residential rehab places have been cut?

Yes. A Freedom of Information investigation by Phoenix Futures, reported by WRD News in April 2026, found that residential rehabilitation placements in England have fallen by roughly 50% over the past decade.

Does the NHS offer any residential rehab at all?

Yes, but access is limited and varies significantly by local authority area. Currently, roughly 1% of people in community drug and alcohol treatment go on to access a residential rehab placement, and around 30% of local authorities report having no defined residential rehab budget at all.

What did the government’s Carol Black review conclude?

Dame Carol Black’s Independent Review of Drugs, Part 2 (2021) concluded that “funding cuts have left treatment and recovery services on their knees.” In response, the government’s 10-year drug strategy, “From Harm to Hope,” committed an additional £532 million to treatment and recovery services between 2022/23 and 2024/25.

Can UK private health insurance help pay for rehab abroad?

Many UK insurers, including Bupa, AXA, Allianz, and Cigna Global, offer policies that partially reimburse treatment at a licensed overseas facility, even though the NHS does not fund treatment abroad. Coverage varies by policy, so it’s worth checking your specific plan. See our full breakdown in “Does Insurance Cover Rehab in Thailand?”

Is private rehab in Thailand safe and properly licensed?

Reputable facilities in Thailand are licensed by the Ministry of Public Health and staffed by accredited clinical professionals with proper medical oversight. Families should verify these credentials directly with any facility they’re considering. Our article “Is Rehab in Thailand Safe?” explains exactly what to check.

What’s the difference between “behavioural health” and “mental health” treatment at Holina?

At Holina, we use “behavioural health” to describe our clinical approach to addiction and co-occurring psychological difficulties, and “dual treatment” rather than “dual diagnosis” to describe care for those conditions together. This reflects our clinical framing of addiction as a behavioural and neurobiological condition treated alongside any underlying psychological factors, rather than treating addiction as a mental illness in isolation.

Does going private mean skipping NHS care entirely?

No. Many families pursue private treatment while an NHS referral is still in progress, and NHS-provided GP and community support often continues alongside or after private treatment, particularly for ongoing aftercare and prescribing needs.

What happens after treatment ends — is there aftercare?

Yes. Holina’s aftercare programme, Thrucare, provides two years of structured support following discharge, covering the period when relapse risk is typically highest. We don’t publish specific retention or outcome statistics for this programme, as we want families to base decisions on documented facts rather than unverified figures.

Clinically reviewed by Dr. Natalie Lindemann — Clinical Director, Holina Global · Last reviewed 18 August 2026.